Results 101 to 110 of about 79,327 (229)
Health Diplomacy in Africa: Prospects, Obstacles, and the Way Ahead
Public Health Challenges, Volume 5, Issue 2, June 2026.ABSTRACT Introduction Africa faces a complex and evolving health landscape marked by endemic diseases, emerging infectious threats, fragile health systems, climate change, and geopolitical pressures. In this context, health diplomacy has become an important mechanism for fostering collaboration, mobilizing resources, and advancing collective health ...
Majani Edward
wiley +1 more source
Malaria Journal, 2005 Background Acute malaria has been associated with a decreased antibody response to tetanus and diphtheria toxoids, meningococcal, salmonella, and Hib vaccines.
Saliou Pierre +9 more
doaj +1 more source
Superstitions on Human Papillomavirus in Africa: A Scoping Review
Public Health Challenges, Volume 5, Issue 2, June 2026.Africa bears a high burden of HPV‐induced diseases; this scoping review explored how superstitions and cultural beliefs fuel vaccine hesitancy. There are widespread myths and opposition from cultural/religious leaders that drive HPV vaccine hesitancy; targeted and culturally sensitive campaigns/educations are essential to improve vaccine uptake and ...
Jimoh Amzat +6 more
wiley +1 more source
Frontiers in ImmunologyBackgroundThe Plasmodium falciparum Rh5-interacting protein (PfRipr) is a key component of the pentameric PTRAMP-CSS-PfRipr-CyRPA-RH5 (PCRCR) complex, which is essential for erythrocyte invasion. Antibodies against PfRipr can inhibit parasite growth, but
Hikaru Nagaoka +3 more
doaj +1 more source
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
Malaria Journal, 2017 In many parts of the African Sahel and sub-Sahel, where malaria remains a major cause of mortality and morbidity, transmission of the infection is highly seasonal.
Brian Greenwood +10 more
doaj +1 more source
Proceedings of a Joint Meeting held between The Norwegian Society of Infectious Diseases and the Royal Society of Tropical Medicine and Hygiene, Oslo, 20th June 2008 [PDF]
, 2009 The Royal Society of Tropical Medicine and Hygiene (RSTMH) has a tradition of holding joint meetings with fellow European Societies, providing opportunities to facilitate discussion, exchange information, foster mutual interests and develop collaboration
Myrvang, Bjorn, Newport, Melanie J.
core +1 more source
Development of a malaria vaccine
The Lancet, 1997 Development of an effective malaria vaccine poses a major scientific challenge both in the laboratory and in the field. Such a vaccine is necessary because of the massive disease burden of malaria in the developing world, the global spread of drug resistance, and the difficulty of sustainable control of the mosquito vector. Animal models have shown the
Kwiatkowski, D, Marsh, K
openaire +3 more sources
BMC Infectious Diseases, 2019 Background The only licensed malaria vaccine, RTS,S/AS01, has been developed for morbidity-control in young children. The potential impact on transmission of deploying such anti-infective vaccines to wider age ranges, possibly with co-administration of ...
Flavia Camponovo +3 more
doaj +1 more source
The Economic Costs of Malaria in Children in three Sub-Saharan Countries: Ghana, Tanzania and Kenya. [PDF]
, 2013 Malaria causes significant mortality and morbidity in sub-Saharan Africa (SSA), especially among children less than five years of age (U5 children).
Constenla, Dagna +4 more
core +2 more sources
Assessing Risk Thresholds in Controlled Human Infection Models (CHIM)
Bioethics, Volume 40, Issue 5, Page 519-529, June 2026.ABSTRACT Controlled Human Infection Models (CHIMs) are a type of clinical trial involving deliberately exposing human volunteers to an infectious agent. Compared to studies of natural infection, CHIMs offers distinctive benefits, from the ability to study presymptomatic infection to a direct assessment of the efficacy of vaccines and therapeutics in a ...
Alexa Nord‐Bronzyk +4 more
wiley +1 more source